# Rivoxar — Calculator > Medical guideline implementation tool with anticoagulation therapy risk calculators. (iPhone/iPad app by Jerusalem pharmaceuticals Co. ltd..) - Source: https://appshunter.io/ios/app/rivoxar/id1568292522 (this page in markdown: same URL + `.md`) - Developer: [Jerusalem pharmaceuticals Co. ltd.](https://appshunter.io/developer/1568292524) - Category: Education - Price: Free - Rating: 5.00/5 from 1 App Store ratings - Age rating: 4+ - Requires: iOS 11.0 · 28 MB - Languages: English - Released: 2021-06-15 - Data updated: 2026-06-22 - Monetization: free - User reviews in markdown: https://appshunter.io/ios/app/rivoxar/id1568292522/reviews.md ## What is Rivoxar? Doctor : RivoXar Application is a tool to help implement international guidelines into medical practice, it contains highly recommended scores that are related to anticoagulation therapy, it contains Calculators of : 1. CHA2DS2-VASc Score: most commonly utilized method to predict thromboembolic risk in atrial fibrillation. 2. HAS-BLED Score: developed as a practical risk score to estimate the 1-year risk for major bleeding in patients with atrial fibrillation. 3. Other (in Progress). · The Application is easy to be used, no personal information neither from you or your patients is needed to be able to use The App. · This guarantees 100% of privacy for you and your patients. · You can have the Username and Password by contacting Jerusalem Pharmaceutical Company representative. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) European Heart Journal (2020) 42, 373_498 • CHA2DS2-VASc Calculator - Figure 12 CHA2DS2-VASc • HAS-BLED Calculator - Table 10 Clinical risk factors in the HAS-BLED score ESC 2020 Guidelines for AF Management https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management This app was developed By Newsoft www.newsoft.ps ## Key features - CHA2DS2-VASc Score Calculator - HAS-BLED Score Calculator - Implements international medical guidelines - 100% patient privacy - Easy to use interface - No personal information required ## Frequently asked questions about Rivoxar ### What is Rivoxar used for? Rivoxar is a medical tool designed to help implement international guidelines into practice. It provides calculators for important scores related to anticoagulation therapy, such as the CHA2DS2-VASc and HAS-BLED scores. ### Does Rivoxar require personal information? No, Rivoxar guarantees 100% privacy. It does not require any personal information from you or your patients to be used, making it a secure tool for medical practice. ### What specific scores can I calculate with Rivoxar? Rivoxar currently offers calculators for the CHA2DS2-VASc Score, which predicts thromboembolic risk in atrial fibrillation, and the HAS-BLED Score, which estimates the risk of major bleeding in patients with atrial fibrillation. ### How is Rivoxar updated? The application was last updated on September 12, 2022, to version 2.4.0. This indicates a commitment to maintaining and improving the tool based on current medical standards and user needs. ### What devices support Rivoxar? Rivoxar is supported on iPhones and iPods. It is designed to be accessible on common Apple mobile devices used by healthcare professionals. ### Is Rivoxar suitable for all ages? Rivoxar has an age rating of 4+, indicating it is broadly accessible. However, its content and functionality are specifically designed for medical professionals managing patient care. ### How can I get a username and password for Rivoxar? To obtain a username and password for Rivoxar, you need to contact a Jerusalem Pharmaceutical Company representative. This process ensures authorized access to the tool. ### What is the user sentiment for Rivoxar? Based on available data, Rivoxar has a perfect rating of 5.0 stars from 1 rating. This suggests a highly positive initial user experience. ## Version history (last 4 releases) ### 2.4.0 — 2022-09-12 -Added Cases button ### 2.2.0 — 2021-07-06 -General Fixes. ### 2.1.0 — 2021-07-04 -General fixes. ### 2.0.0 — 2021-06-15 No release notes. --- *Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-22.*